PHARMACOKINETIC STUDY OF BRAMITOB ADMINISTERED FOR INHALATION BY PARI eFLOW RAPID ELECTRONIC NEBULIZER VS PARI LC PLUS NEBULIZER COUPLED WITH THE PARI TURBO BOY N COMPRESSOR IN CYSTIC FIBROSIS PATIENTS INFECTED WITH PSEUDOMONAS AERUGINOSA.
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2012
At a glance
- Drugs Tobramycin (Primary)
- Indications Pseudomonal infections
- Focus Pharmacokinetics
- 16 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 16 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2011 Additional lead trial investigators identified and additional locations identified as reported by ClinicalTrials.gov.